drugset / Trial / NCT01569035
Warfarine in Unexplained Oligohydramnios
NaSingle-groupDouble-blindTreatment
Summary
This study examines using oral anti coagulant warfarin in the management of unexplained oligohydramnios improve the perinatal outcome with little or no complications to the mother or the neonates.
Timeline
- Start
- 2009-01
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Warfarin | Small molecule | 3 mg | Oral |